LIPIDSOL
Live / Registered — Registered (as of 10 Jun 2025)
What this means for you
Registered since 10 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97690235
- Registration number
- 7827536
- Mark type
- Stylized text
- Filed
- 23 Nov 2022
- Published for opposition
- 17 Oct 2023
- Registered
- 10 Jun 2025
- Attorney of record
- James Klobucar
Goods and services
- Class 042 — Scientific and technological services: pharmaceutical drug development services in the field of nanoparticles and liposomes; pharmaceutical research and development; pharmaceutical research services
Owner
- Ascendia Pharmaceuticals, Inc., North Brunswick, NJ, US
- Ascendia Pharmaceuticals, Inc., North Brunswick, NJ, US
- Ascendia Pharmaceuticals, Inc., North Brunswick, NJ, US
Prosecution history
- 10 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 20 May 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 May 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Jun 2024 — USE AMENDMENT FILED
- 29 Jul 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Jun 2024 — TEAS STATEMENT OF USE RECEIVED
- 12 Dec 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Oct 2023 — PUBLISHED FOR OPPOSITION
- 27 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Sept 2023 — ASSIGNED TO EXAMINER
- 16 Dec 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED